36E79726R0032 Lisinopril Tablets (VA-27-00004937)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79726R0032

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued a solicitation (Procurement Identifier: 36E79726R0032) for the supply of Lisinopril Tablets under the reference VA-27-00004937. This procurement seeks to secure a reliable source of Lisinopril Tablets, a widely used pharmaceutical product, to support the ongoing healthcare needs of veterans served by the VA healthcare system. The scope of this solicitation encompasses the manufacturing and delivery of Lisinopril Tablets, in accordance with the standards and requirements set forth by the VA. The intended outcome is to ensure a consistent and high-quality supply of this essential medication, which is commonly prescribed for the treatment of hypertension and heart failure among the veteran population. Contractors are expected to adhere to all applicable regulatory and quality assurance standards relevant to pharmaceutical preparation manufacturing. This opportunity is classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing), as per the 2022 NAICS version, and is further identified by Product Service Code 6505, which pertains to drugs and biologicals. The procurement is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this solicitation is Youlanda Duggar, who can be reached via email at [email protected] for any inquiries or clarifications regarding the solicitation requirements. The solicitation is currently active, with a posting date of March 9, 2026, and a response deadline of September 24, 2026. Interested contractors are encouraged to review the attached documents available through the official notice on SAM.gov (Opportunity ID: f6fd014334c642a69af2341f78fb03fc) for detailed specifications, submission instructions, and any additional requirements. The notice does not specify any set-aside requirements or special considerations; therefore, all qualified manufacturers within the relevant NAICS code are invited to participate. Contractors evaluating this opportunity should ensure their capabilities align with the VA’s stringent quality and regulatory expectations for pharmaceutical products. The contract will require consistent adherence to federal standards throughout its lifecycle, with a focus on reliability, quality, and compliance. For further information and access to solicitation documents, interested parties should refer to the official notice URL: https://sam.gov/opp/f6fd014334c642a69af2341f78fb03fc/view.